Most recent comments


See all comments
Leave your own comments

Nickname: Mary
Review: I thought Panitumumab WAS/IS Amgen's drug because Amgen bought the company that was it helping develop this cancer therapy (Abgenix). Where's the rivalry? I'm confused. Thanks, Mary
Date reviewed: Jan 25, 2006 3:33 PM
See all comments
Leave your own comments



The views and opinions expressed in these comments do not necessarily reflect the views or opinions of BusinessWeek or the McGraw-Hill Companies.